AGENDA. 8:15-8:25am Special Message U.S. Surgeon General, Jerome M. Adams, MD, MPH, VADM, USPHS (Video)

Transcription

1 AGENDA 8:00-8:15am NG 3 Pickens Auditorium Welcome Daniel K. Podolsky, MD, President, UT Southwestern Medical Center Mehran S. Massoudi, PhD, MPH, CAPT, U.S. Public Health Service (USPHS), U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Health (OASH), Regional Health Administrator, Region VI David Teuscher, MD, HHS, Intergovernmental and External Affairs, Regional Director, Region VI Karen Hearod, LCSW, CDR, USPHS, Substance Abuse and Mental Health Services Administration (SAMHSA), HHS, Regional Administrator, Region VI Marcy Paul, PhD, Assistant Professor, University of North Texas Health Science Center, School of Public Health, Department of Health Behaviors and Health Systems - Conference Facilitator To provide the schedule for the day, and brief introduction to speakers for morning sessions, discuss afternoon breakouts and call for future work on opioids. Throughout the day she will weave in future work on opioids such as, opportunities to join a Region VI opioid workgroup, and discussion of region VI opioid webinars and conferences scheduled for summer :15-8:25am Special Message U.S. Surgeon General, Jerome M. Adams, MD, MPH, VADM, USPHS (Video) 8:25-8:55am National and Regional Data Beyond the Numbers Christopher Jones, PharmD, MPH, CAPT, USPHS, Director, National Mental Health and Substance Use Policy Laboratory, SAMHSA Esteban Gershanik, MD, MPH, MMSc, FAAP, FHM, Director, Bureau of Health Informatics, Louisiana Department of Health and Hospitals 8:55-9:10am Pain Management/Best Practices The U.S. Government s Response to Pain in the Opioid Crisis Vanila Singh, MD, MACM, Chief Medical Officer, HHS/OASH 9:10-9:25am Acute Pain and Opioids Carl Noe, MD, Professor, Anesthesiology and Pain Management, Clinical Psychology, UT Southwestern Medical Center 1

2 9:25-9:45am U.S. Congress Perspective Why is the Opioid Epidemic a Priority? Moderator: Mehran S. Massoudi, PhD, MPH, HHS Regional Health Administrator The Honorable Chairman Pete Sessions, (32 nd District TX), Chairman, House Committee on Rules, U.S. House of Representatives Q & A Session 9:45-10:00am Preventing Opioid Misuse and Abuse in the States and Territories: A Public Health Framework for Cross-Sector Leadership 10:00-10:15am Morning Break Michael Fraser, PhD, CAE, Executive Director, Association of State and Territorial Health Officials 10:15-11:00am NG 3 Pickens Auditorium Panel Discussion: State of the Region VI States Opioid Efforts Moderator: David Teuscher, MD, HHS Regional Director, Region VI State Officials to provide an overview of opioid endeavors: Arkansas Kirk Lane, Arkansas Drug Director Louisiana James Hussey, MD, Louisiana Department of Health New Mexico Keith Gardner, Chief of Staff, New Mexico Office of the Governor Oklahoma Lori Carter, Director of Legislative Affairs, Oklahoma Office of the Attorney General Texas John Hellerstedt, MD, Commissioner, Texas Department of State Health Services 11:00-12:15pm Panel Discussion - 1 st Responders Stories from the Field Taking it to the Streets Moderator: Malini Ghoshal, RPh MS, President, Inspira Healthcare EMS Perspective George Gamez, Deputy Chief, Dallas Fire and Rescue Department Recovery Perspective Joe Powell, President and CEO, Association of Persons Affected by Addiction Judicial Perspective Judge Lela Mays, Founder, Successful Treatment of Addiction through Collaboration (S.T.A.C.) Court, Aux. Court 6 Law Enforcement Perspective Kirk Lane, Arkansas Drug Director 12:15-12:20pm Summary of Morning Sessions and Overview of Afternoon Sessions 12:20-1:15pm Lunch Afternoon Breakout Sessions as Assigned 2

3 1:15-2:30pm Room: NG (RED) Room: NG 3 (YELLOW) Special Populations: Solution-Based Breakout Sessions SESSION 1 Ensuring a Smooth Start: Addressing Maternal Child Health and Neonatal Abstinence Syndrome Facilitator: Lakesha Pope Jackson, HHS, Administration for Children and Families, Regional Administrator, Region VI Maternal/Child Health and Neonatal Abstinence Larry Leeman, MD, Professor Family and Community Medicine; Obstetrics and Gynecology, University of New Mexico 1. Describe the incidence of NAS in the US 2. Identify drugs associated with NAS 3. Describe options for treatment of opioid dependence during pregnancy 4. Describe a family-centered model of care for women with substance abuse in pregnancy 5. Describe the appropriate way to assess neonates for signs of NAS 6. Understand diagnosis and management of neonatal opioid withdrawal syndrome 7. Identify non-pharmacologic, pharmacologic and caregiving strategies for managing neonates with NAS SESSION 2 A Path Forward: Recovery-Oriented Systems of Care Facilitators: Jackson Longan, Regional Manager, Oxford House, Texas Jeff Mouakket, RPh, MPH, CDR, USPHS, HHS, Centers for Medicare & Medicaid Services (CMS), Regional Pharmacist, Region VI Medication Assisted Treatment/Prescription Drug Monitoring Program Gene Shelby, MD, Emergency Medicine, Chairman, Arkansas Prescription Drug Monitoring Program Advisory Committee Medication Assisted Recovery/Treatment Katie Sherman, Opioid Treatment Expert, Texas Targeted Opioid Response, Substance Use Disorder Unit, Behavioral Health Services Section, Texas Health and Human Services Commission Innovative Pain Management Techniques Michael Brand, LCSW, LMFT, PhD, Associate Professor, Department of Psychiatry and Behavioral Science, University of Oklahoma College of Medicine Recovery Oxford House Assisted Recovery Care 3

4 Jackson Longan, Regional Manager, Oxford House, Texas Peer Assisted Recovery/Recovery Supports Joe Powell, President and CEO, Association of Persons Affected by Addiction 1. Discuss recovery housing models and learn about the Oxford House concept, purpose and structure 2. Explore the role of peer recovery support specialists and other forms of recovery supports 3. Describe Medication Assisted Treatment 4. Describe Medication Assisted Recovery 5. Identify differences between Medicated Assisted Treatment and Recovery 6. Identify barriers and opportunities to establishing Recovery Oriented Systems of Care Room: ND 14 (BLUE) SESSION 3 Finding and Serving Special Populations Where They re at: Rural, Primary Care, and Veteran Settings and Use of Telemedicine Facilitators: Hernan Reyes, MD, CAPT, USPHS, HHS, Health Resources Services Administration (HRSA), Deputy Regional Administrator, Region VI David Nilasena, MD, HHS, CMS, Chief Medical Officer, Region VI Telehealth Miriam Komaromy, MD, FACP, FASAM, Associate Director, Extension for Community Healthcare Outcomes (ECHO) Institute, University of New Mexico Behavioral Health Integration into the Primary Care Setting Hernan Reyes, MD, CAPT, USPHS, HHS, HRSA, Deputy Regional Administrator, Region VI Helping Veterans Fight Opioid Addiction John W. Klocek, PhD, Technical Assistance Specialist, Office of Mental Health & Suicide Prevention, VA Central Office 1. Describe the ECHO Project 2. Describe the role of tele-health/echo Institute in supporting clinicians treating Opioid Use Disorder 3. Discuss ways that the Integrated Care Model can expand access to treatment 4. Describe special considerations in opioid misuse prevention and treatment with Veterans 5. Describe innovative treatment strategies in pain management 4

5 2:30-2:45pm Afternoon Break 2:45-4:00pm Room: NG 3 (GREEN) Room: NG (ORANGE) Special Populations: Solution-Based Breakout Sessions SESSION 1 Promising Practices in Public Safety Facilitator: Michael Coulter, HHS, CMS, Health Insurance Specialist, Region VI Overdose Reversing Drugs Eduardo A. Chavez, Assistant Special Agent In Charge, Drug Enforcement Administration (DEA) Two Court System Judge Lela Mays, Founder, Successful Treatment of Addiction through Collaboration (S.T.A.C.) Court, Aux. Court 6 Julie Turnbull, Assistant District Attorney, Dallas County Denean Kline, LPC-S, Supervisor, North Texas Behavioral Health 1. Provide a description of each of the programs discussed 2. Identify barriers that exist within systems for those that they serve to be successful in recovery 3. Identify opportunities for increased coordination enhanced communication between systems 4. Identify current successes, needs, future strategies SESSION 2 Promising Practices for Tribal Communities Facilitator: Kristie Brooks, LPC, Director, Choctaw Nation Behavioral Health Tribal Champions/Opioid Work in Indian Country Paul Pierce, MD, Chief Psychiatrist, Indian Health Service (IHS) Barbara Roland, LPC, Oklahoma City Area Behavioral Health Director, (IHS) 1. Discuss the impact of opioid misuse in Tribal Communities. 2. Explore the role of Tele-Health in treating OUD. 3. Identify barriers specific to serving Tribal populations in implementing prevention, treatment, and recovery strategies related to opioid misuse. 4. Identify opportunities specific to serving Tribal populations in implementing prevention, treatment, and recovery strategies related to opioid misuse. 5

6 Room: ND 14 (BLACK) SESSION 3 Innovative Practices in Special Settings: Schools, Communities, and Faith- Based Organizations Facilitator: Sylvia Garcia, HHS, CMS, Health Insurance Specialist, Region VI School-Based Solutions Wayne Lindstrom, Director, New Mexico Behavioral Health Services Division Implementation of Good Behavior Game Community Best Practices John Haenes, CEO, Challenge of Tarrant County Faith-Based Solutions Rev. Stephen Copley, Executive Director, Interfaith Arkansas 1. Explore innovative practices in prevention misuse of opioids in schools, communities, and faith-based settings. 2. Identify opportunities for partnership and collaboration with local, state, and federal partners. 3. Identify current success, needs, and future strategies. 4:00-4:15pm Afternoon Break 4:15-4:45pm NG 3 Pickens Auditorium Conference Facilitator will summarize the morning and afternoon sessions, including breakouts. Main topics and next steps will be discussed in light of upcoming activities and ways to keep communications going. Call to Action Evaluations Funding for the Region VI Opioid Summit: Generating Action Strategies to Address the Opioid Epidemic was made possible by The Substance Abuse and Mental Health Services Administration (SAMHSA), Regional Administrator, Region VI and The Office of the Regional Health Administrator (ORHA), Office of the Assistant Secretary for Health (OASH), Region VI, Department of Health and Human Services. 6